Clinical Trials Update: July 21, 2006
Acute Myelogenous Leukemia (AML) Heart Attack (Myocardial Infarction) or Obesity Osteoarthritis
(HealthDay News) -- Here are the latest clinical trials, courtesy of Thomson CenterWatch:
Acute Myelogenous Leukemia (AML)
A clinical trial is seeking subjects with acute myelogenous leukemia (AML) in either first complete remission with poor prognostic features or second complete remission to participate in a clinical study to test an experimental drug.
Those who qualify for this study should be at least 18-years-old who have not received a marrow, blood, cord blood transplant, or solid organ transplant and who are not taking corticosteroids at doses equivalent to or greater than 10 mg/day of prednisone.
The research site is in New York City.
Heart Attack (Myocardial Infarction) or Obesity
People with a serious heart condition are asked to participate in this research study.
Successful candidates should be at least 55-years-old, male and have a waistline of over 40 inches or female and have a waistline of over 35 inches, and have had at least one significant heart condition including -- but not limited to -- heart attack, chest pain, peripheral artery disease (PAD), type 2 diabetes, high cholesterol.
You may not participate in this study if you have had weight loss surgery (stomach stapling, etc.) within the past 6 months or participated in a research trial involving the study drug rimonabant.
The research site is in the Bronx, New York.
If you have osteoarthritis (OA) pain of the knee or hip, you may be eligible for a research study of an investigational pain medication.
Volunteers between the ages of 21 and 80 who are currently taking pain medication for osteoarthritis may be eligible for this study. Qualified participants may receive investigational study medication, study-related physical exams and lab tests, and compensation for time and travel.
Research sites are located throughout the United States.
Copyright 2006 Thomson CenterWatch. All rights reserved.